HB 1099: reschedule the pharmaceutical composition of crystalline polymorph psilocybin in a drug…
9 links on this map: who funds them, what they touched, and who lobbied on it. Select anyone to move the map to them.
Start with
and connect to
Browse all held record sources
Zoom to read. Drag to explore. Select a connection.
HB 1099
reschedule the pharmaceutical composition of crystalline polymorph psilocybin in a drug product approved by the Food and Drug Administration as a Schedule IV controlled substance
South Dakota · Became law
Every link on this map
The same connections as a table, with the reason each one is here.
| Scott Moore | Sponsors | Scott Moore sponsored HB 1099: reschedule the pharmaceutical composition of crystalline polymorph psilocybin in a drug…. | None |
| Eric Emery | Sponsors | Eric Emery sponsored HB 1099: reschedule the pharmaceutical composition of crystalline polymorph psilocybin in a drug…. | None |
| Brandon Wipf | Sponsors | Brandon Wipf sponsored HB 1099: reschedule the pharmaceutical composition of crystalline polymorph psilocybin in a drug…. | None |
| Brian Mulder | Sponsors | Brian Mulder sponsored HB 1099: reschedule the pharmaceutical composition of crystalline polymorph psilocybin in a drug…. | None |
| Tom Pischke | Sponsors | Tom Pischke sponsored HB 1099: reschedule the pharmaceutical composition of crystalline polymorph psilocybin in a drug…. | None |
| Taylor Rehfeldt | Sponsors | Taylor Rehfeldt sponsored HB 1099: reschedule the pharmaceutical composition of crystalline polymorph psilocybin in a drug…. | None |
| Erik Muckey | Sponsors | Erik Muckey sponsored HB 1099: reschedule the pharmaceutical composition of crystalline polymorph psilocybin in a drug…. | None |
| Mellissa Heermann | Sponsors | Mellissa Heermann sponsored HB 1099: reschedule the pharmaceutical composition of crystalline polymorph psilocybin in a drug…. | None |
| reschedule the pharmaceutical composition of crystalline polymorph psilocybin in a drug product approved by the Food and Drug Administration as a Schedule IV controlled substance. | Source records | HB 1099: reschedule the pharmaceutical composition of crystalline polymorph psilocybin in a drug… has an explicit source reference to reschedule the pharmaceutical composition of crystalline polymorph psilocybin in a drug product approved by the Food and Drug Administration as a Schedule IV controlled substance.. | None |
In the news
Reporting about the selected subject. Articles are context and do not establish a connection on this map.
Loading coverage…